SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-11-002580
Filing Date
2011-09-12
Accepted
2011-09-12 16:25:14
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-K zk1110396.htm 10-K 2081390
2 EXHIBIT 10.2 exhibit_10-2.htm EX-10.2 40152
3 EXHIBIT 10.5 exhibit_10-5.htm EX-10.5 1213039
4 EXHIBIT 10.8 exhibit_10-8.htm EX-10.8 4846
5 EXHIBIT 14.1 exhibit_14-1.htm EX-14.1 62142
6 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 4185
7 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10019
8 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 10153
9 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5416
10 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5588
11 ey_color.jpg GRAPHIC 12814
12 pluristem.jpg GRAPHIC 3583
  Complete submission text file 0001178913-11-002580.txt   3461032
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-31392 | Film No.: 111085950
SIC: 2836 Biological Products, (No Diagnostic Substances)